Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77 | 177 | 337 | 0 | 0 |
| Marketable Securities | 163 | 277 | 228 | 0 | 0 |
| Inventories | 27 | 27 | 27 | 0 | 0 |
| TOTAL | $306 | $521 | $626 | $0 | $0 |
| Non-Current Assets | |||||
| Intangibles | 29 | 29 | 29 | 0 | 0 |
| Other Non-Current Assets | 200 | 200 | 200 | 0 | 0 |
| TOTAL | $229 | $229 | $229 | $N/A | $N/A |
| Total Assets | $536 | $751 | $855 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5 | 13 | 22 | 0 | 0 |
| Accounts payable and accrued liabilities | 28 | 46 | 26 | 0 | 0 |
| TOTAL | $33 | $58 | $48 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 400 | 400 | 400 | 0 | 0 |
| TOTAL | $400 | $400 | $400 | $N/A | $N/A |
| Total Liabilities | $433 | $458 | $448 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,468 | 23,442 | N/A | N/A | N/A |
| Common Shares | 2 | 2 | 2 | 0 | 0 |
| Retained earnings | -2,008 | -1,766 | -1,643 | 0 | 0 |
| TOTAL | $103 | $293 | $407 | $0 | $0 |
| Total Liabilities And Equity | $536 | $751 | $855 | $0 | $0 |